Clinical Updates & Treatment Advances in Metastatic Cervical Cancer from SGO


 

SGO 2022 Phase II Trial of Maintenance Niraparib in Stage III/IV or Platinum-Sensitive Recurrent Uterine Serous Carcinoma

194 views
April 7, 2022
0 Comments
Login to view comments. Click here to Login
Clinical Updates & Treatment Advances in Metastatic Cervical Cancer from SGO